Download our scientific poster "IVDR performance studies demonstrate a sensitive and accurate aneuploidy test"
Sign-up to watch our symposium on the latest advancements in next-generation automated genetic testing for cystic fibrosis and familial hypercholesterolemia shared by our esteemed speakers Prof. Milan Macek and Silvia Borras.
Next Generation Sequencing: Changing the game in CFTR analysis
This whitepaper is authored by Stewart Payne, Consultant Clinical Scientist at UK National Health Service and Head of Molecular Genetics in the North West Thames Regional Genetics since 1995. Stewart’s laboratory was one of few in the UK offering CFTR whole gene analysis by Sanger sequencing and has recently translated whole gene analysis to next generation sequencing.
- How NGS enables routine screening of all published CFTR mutations.
- Categories of CFTR mutations and interpretation of CFTR mutation data.
- What the future holds for CFTR diagnostics and targeted therapies.
How can we help your lab?
IVDR-certified test kits are often more cost-effective than alternative solutions, such as developing your own in-house LDTs. By choosing an IVDR-certified product, you can save time and resources while still receiving the highest-quality results.
IVDR-certified test kits are designed to be user-friendly and efficient, saving you time and resources in your laboratory operations and improving patient outcomes.
Compliance with regulations
With the implementation of the IVDR, buying IVDR-certified test kits is essential for compliance with European Union regulations. By purchasing from a trusted provider, you can be confident that you are meeting all the necessary requirements and avoiding costly penalties.
At the end of the day, it is all about ensuring safety and accuracy for patients.
Insight and inspiration
News | January 17, 2024
Devyser Genomic Laboratories signs first commercial agreement
Devyser Genomic Laboratories, Devyser's US-based CLIA-certified laboratory, has signed its first commercial agreement with UK based diagnostics company Cyted.Find out more
News | January 15, 2024Devyser wins tender for cystic fibrosis in Italy
News | Jan 08, 2024Devyser signs in vitro diagnostic agreement with Illumina to broaden access to its tests
News | December 12, 2023Devyser wins tender for non-invasive fetal RHD testing in Wales
Latest from the Devyser blogView all
Devyser’s NGS products for monitoring of kidney and stem cell transplant patients receive IVDR approvals
Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from...
Early detection of relapse and early therapeutic intervention: The benefits of Devyser NGS method for chimerism analysis
A better patient care is the final objective for Dr. Helena Devos and the team at Sint Jan’s...
Devyser enters agreement with Thermo Fisher Scientific for commercialization of Devyser’s post-transplant NGS products
Collaboration and distribution agreement with Thermo Fisher Scientific Thermo Fisher Scientific...